23 September 2021: Articles
Treatment of a Gastrointestinal Sarcoidosis Flare: A Multidisciplinary Approach for a Multisystem Disease
Unusual or unexpected effect of treatment, Rare disease, Rare coexistence of disease or pathology
Neil Nadpara A* , Holly S. Greenwald A , Henry P. Parkman EDOI: 10.12659/AJCR.932494
Am J Case Rep 2021; 22:e932494
Table 1. Symptoms, interventions, and outcomes for a patient with gastric sarcoidosis.
| Symptom and duration | Prior interventions | Present interventions | Outcomes at follow-up |
|---|---|---|---|
| Two months epigastric pain | PPI therapy, taken intermittently | Steroids, PPI and H2RA, bowel regimen | Reported pain 0/10 epigastric pain |
| Two months dysphagia | PPI therapy, taken intermittently | Steroids PPI, Speech therapy consultation with education on liquid wash during solid meals | Resolution of symptoms on follow-up |
| Two months nausea with emesis | PPI therapy, taken intermittently | Steroids, PPI | No antiemetic needed on discharge or at follow-up |
| PPI – proton pump inhibitor; H2RA – histamine receptor 2 antagonist. | |||